Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori
In the process of endourological development a variety of foreign bodies have been invented besides urinary catheters, on which biofilm can be formed. Bacteria in the biofilm are less susceptible to antibiotics. An additional problem of medical biomaterials in the urinary tract environment is the de...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2004
|
| Sorozat: | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
23 No. 6 |
| doi: | 10.1016/j.ijantimicag.2003.11.010 |
| mtmt: | 1158125 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/10264 |
| LEADER | 01854nab a2200277 i 4500 | ||
|---|---|---|---|
| 001 | publ10264 | ||
| 005 | 20190522150021.0 | ||
| 008 | 170113s2004 hu o 0|| zxx d | ||
| 022 | |a 0924-8579 | ||
| 024 | 7 | |a 10.1016/j.ijantimicag.2003.11.010 |2 doi | |
| 024 | 7 | |a 1158125 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Spengler Gabriella | |
| 245 | 1 | 0 | |a Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori |h [elektronikus dokumentum] / |c Spengler Gabriella |
| 260 | |c 2004 | ||
| 300 | |a 631-633 | ||
| 490 | 0 | |a INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |v 23 No. 6 | |
| 520 | 3 | |a In the process of endourological development a variety of foreign bodies have been invented besides urinary catheters, on which biofilm can be formed. Bacteria in the biofilm are less susceptible to antibiotics. An additional problem of medical biomaterials in the urinary tract environment is the development of encrustation and consecutive obstruction. The most promising prevention strategy for bacterial biofilms is the production of materials with anti-adhesive surfaces such as heparin. Although heparin-coated ureteral stents are expensive, they justify their cost. Our studies show that such devices are protected against incrustation and biofilm formation for a longer period of time: 6-12 months, both in vitro and in vivo. © 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. | |
| 700 | 0 | 1 | |a Molnár Annamária |e aut |
| 700 | 0 | 1 | |a Klausz Gergely |e aut |
| 700 | 0 | 1 | |a Mándi Yvette |e aut |
| 700 | 0 | 1 | |a Kawase Masami |e aut |
| 700 | 0 | 1 | |a Motohashi Noboru |e aut |
| 700 | 0 | 1 | |a Molnár József |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/10264/1/1158125.pdf |z Dokumentum-elérés |